GenomOncology
Healthcare Software · Ohio, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1138 W 9th St Ste 400, Cleveland, Ohio, ...Phone Number
(440) 617-6087Website
www.genomoncology.comRevenue
$147.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About GenomOncology
GenomOncology provides a precision oncology platform designed to enhance clinical decision support for healthcare professionals. Their software solutions cater to oncologists, molecular pathologists, lab directors, clinical researchers, and bioinformaticians, aiming to streamline workflows and improve patient outcomes. The platform integrates diverse oncology data, enabling faster and more informed decision-making while addressing challenges such as fragmented data and operational bottlenecks. With a commitment to optimizing cancer care, GenomOncology empowers institutions to deliver precision medicine effectively and efficiently.Explore more
GenomOncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GenomOncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when GenomOncology launches new products
Earning: See what the market has to say on GenomOncology recently announced quarterly report
Check if GenomOncology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if GenomOncology had a recent Job posting/layoffs
GenomOncology, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if GenomOncology is spiking on competitors!
Funding: Get notified immidiatlly once GenomOncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at GenomOncology
Recommended Actions
Reach out to Masked Content who joined GenomOncology as Masked Content
Find 2 more new buyers
Compare Similar Companies to GenomOncology
Compare insights from companies similar to GenomOncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GenomOncology is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
GenomOncology is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about GenomOncology.
GenomOncology financials insights
Gather financial insights about GenomOncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$1.3M
2020
Debt
$350K
GenomOncology Tech Stack
A closer look at the technologies used by GenomOncology
See more technologies
Most Recent Scoops
Partnership
Partnership, Engineering, Clinical Systems, Business Development, Health & Fitness, Artificial Intelligence, Healthcare Technology
Person-Based
Clinical Operations
Person-Based
Partnership, Clinical Operations
Person-Based
Person-Based
GenomOncology News & Media
GenomOncology Partners with OHSU Knight Diagnostics Lab to Accelerate Patient Access to Precision Oncology Clinical Trials
CLEVELAND, Jan. 14, 2026 /PRNewswire/ -- GenomOncology (GO), a leader in precision medicine reporting solutions, today announced a strategic partnership with Oregon Health & Science University's (OHSU) Knight Diagnostics Lab (KDL) to enhance clinical trial matching for cancer patients....GenomOncology Partners with Glioblastoma Foundation to Accelerate Precision Glioblastoma Brain Cancer Treatment
CLEVELAND and DURHAM, N.C., Nov. 11, 2025 /PRNewswire/ -- GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation's most aggressive brain cancer, glioblastoma. The collaboration integrates GenomOncology's advanced...GenomOncology Announces BioMCP: Open Source Model Context Protocol (MCP) for Biomedical AI Assistants and Agents
CLEVELAND, April 10, 2025 /PRNewswire/ -- GenomOncology today announced BioMCP, a new open-source technology that helps artificial intelligence (AI) systems access specialized medical information. BioMCP supports advanced searching and full-text retrieval from clinical trials, genetic...GenomOncology Partners with Chronetyx Laboratories to Accelerate Cancer Care Through Comprehensive Genomic Profiling
CLEVELAND, March 31, 2025 /PRNewswire/ -- GenomOncology, a precision medicine software company, today announced a strategic partnership with Chronetyx Laboratories, a leading provider of advanced diagnostic solutions, that will significantly reduce turnaround times for next-generation...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GenomOncology
Sign Up For FreeTo access detailed company insights
GenomOncology provides a precision oncology platform designed to enhance clinical decision support for healthcare professionals. Their software solutions cater to oncologists, molecular pathologists, lab directors, clinical researchers, and bioinformaticians, aiming to streamline workflows and improve patient outcomes. The platform integrates diver... Read More
